Il trattamento topico delle riniti allergiche e vasomotorie: Il ruolo del beclometasone dipropionato

Translated title of the contribution: The topical treatment of allergic and vasomotor rhinitis: The role of beclomethasone dipropionate

Giorgio Ciprandi, Giovanni A. Rossi

Research output: Contribution to journalArticle

Abstract

Allergic rhinitis is the most frequent allergic disorder, as its prevalence is more than 20% in the general population. Non-allergic rhinitis has similar symptoms, but pathogenic mechanisms are non-IgE-mediated. Anyway, both diseases share a common inflammatory pathway, thus anti-inflammatory drugs represent the optimal therapeutical option. Beclomethasone dipropionate (BDP) is a corticosteroid that is long time available both as intranasal spray and aerosol solution. The present review aims at analysing the most relevant and recent studies concerning the BDP use in allergic and non-allergic rhinitis. The research was performed using Medline and Scopus database, key words were: allergic and non-allergic rhinitis, beclomethasone (last access 31st July 2014). BDP is a corticosteroid with proved efficacy in the treatment of rhinitis, both as spray and aerosol. Safety issue has been satisfactory explored, thus BDP is usually safe and well tolerated.

Translated title of the contributionThe topical treatment of allergic and vasomotor rhinitis: The role of beclomethasone dipropionate
Original languageItalian
Pages (from-to)420-428
Number of pages9
JournalRecenti Progressi in Medicina
Volume105
Issue number11
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The topical treatment of allergic and vasomotor rhinitis: The role of beclomethasone dipropionate'. Together they form a unique fingerprint.

  • Cite this